The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Increased PADI4 expression in blood and tissues of patients with malignant tumors
Open accessAbstract
BACKGROUND: Peptidylarginine deiminase type 4 (PAD4/PADI4) post-translationally converts peptidylarginine to citrulline. Recent studies suggest that PADI4 represses expression of p53-regulated genes via citrullination of histones at gene promoters. METHODS: Expression of PADI4 was investigated in various tumors and non-tumor tissues (n = 1673) as well as in A549, SKOV3 and U937 tumor cell lines by immunohistochemistry, real-time PCR, and western blot. Levels of PADI4 and citrullinated antithrombin (cAT) were investigated in the blood of patients with various tumors by ELISA (n = 1121). RESULTS: Immunohistochemistry detected significant PADI4 expression in various malignancies including breast carcinomas, lung adenocarcinomas, hepatocellular carcinomas, esophageal squamous cancer cells, colorectal adenocarcinomas, renal cancer cells, ovarian adenocarcinomas, endometrial carcinomas, uterine adenocarcinomas, bladder carcinomas, chondromas, as well as other metastatic carcinomas. However, PADI4 expression was not observed in benign leiomyomas of stomach, uterine myomas, endometrial hyperplasias, cervical polyps, teratomas, hydatidiform moles, trophoblastic cell hyperplasias, hyroid adenomas, hemangiomas, lymph hyperplasias, schwannomas, neurofibromas, lipomas, and cavernous hemangiomas of the liver. Additionally, PADI4 expression was not detected in non-tumor tissues including cholecystitis, cervicitis and synovitis of osteoarthritis, except in certain acutely inflamed tissues such as in gastritis and appendicitis. Quantitative PCR and western blot analysis showed higher PADI4 expression in gastric adenocarcinomas, lung adenocarcinomas, hepatocellular carcinomas, esophageal squamous cell cancers and breast cancers (n = 5 for each disease) than in the surrounding healthy tissues. Furthermore, western blot analysis detected PADI4 expression in cultured tumor cell lines. ELISA detected increased PADI4 and cAT levels in the blood of patients with various malignant tumors compared to those in patients with chronic inflammation and benign tumors. This was consistent with immunohistochemical results. Additionally, PADI4 and cAT levels were significantly associated with higher levels of known tumor markers. CONCLUSION: Our results suggest that PADI4 expression is increased in the blood and tissues of many malignant tumors, a finding useful for further understanding of tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The human keratins: biology and pathology
Moll, R., Divo, M., & Langbein, L. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0435-6 · Cited by 1,465
Suzuki, A., Yamada, R., Chang, X., Tokuhiro, S., Sawada, T., Suzuki, M., Nagasaki, M., Nakayama-Hamada, M., Kawaida, R., Ono, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1206 · Cited by 1,168
Self-citationHistone Deimination Antagonizes Arginine Methylation
Cuthbert, G. L., Daujat, S., Snowden, A. W., Erdjument-Bromage, H., Hagiwara, T., Yamada, M., Schneider, R., Gregory, P. D., Tempst, P., Bannister, A. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.08.020 · Cited by 839
Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance
Hristov, M., & Weber, C. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00474.x · Cited by 477
Mechanisms of the inflammatory response
Sherwood, E. R., & Toliver-Kinsky, T. (2004) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2003.12.002 · Cited by 408
Regulation of p53 Target Gene Expression by Peptidylarginine Deiminase 4
Li, P., Yao, H., Zhang, Z., Li, M., Luo, Y., Thompson, P. R., Gilmour, D. S., & Wang, Y. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01747-07 · Cited by 220
Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors
Chang, X., & Han, J. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20169 · Cited by 185
Self-citationApoptosis and keratin intermediate filaments
Oshima, R. G. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400988 · Cited by 181
Denkert, C., Koch, I., von Keyserlingk, N., Noske, A., Niesporek, S., Dietel, M., & Weichert, W. (2006) · Modern Pathology · doi:10.1038/modpathol.3800645 · Cited by 168
Histone Arg Modifications and p53 Regulate the Expression of OKL38, a Mediator of Apoptosis
Yao, H., Li, P., Venters, B. J., Zheng, S., Thompson, P. R., Pugh, B. F., & Wang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802940200 · Cited by 160
Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma
Hammoud, Z. T., Tan, B., Badve, S., & Bigsby, R. M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0002 · Cited by 119
Mechanism of thrombin-induced angiogenesis
Maragoudakis, M. E., Tsopanoglou, N. E., & Andriopoulou, P. (2001) · Biochemical Society Transactions · doi:10.1042/bst0300173 · Cited by 103
Associations between ERα, ERβ, and AR Genotypes and Colon and Rectal Cancer
Slattery, M. L., Sweeney, C., Murtaugh, M. A., Ma, K.-N., Wolff, R. K., Potter, J. D., Caan, B. J., & Samowitz, W. S. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0514 · Cited by 100
Moore, T. T., & Lee, A. H. S. (2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01053.x · Cited by 98
Coagulation proteases and human cancer
Sampson, M. T., & Kakkar, A. K. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300201 · Cited by 75
Aromatase Expression in Women’s Cancers
Bulun, S. E., & Simpson, E. R. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78818-0_8 · Cited by 70
Dong, S., Zhang, Z., & Takahara, H. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0550 · Cited by 70
Chang, X. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh473 · Cited by 61
Self-citationIs human hepatocellular carcinoma a hormone-responsive tumor?
Maïo, M. D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1682 · Cited by 53
Accumulation of ubiquitin-conjugated cytokeratin fragments in tumor cells
Iwaya, K., & Mukai, K. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.006 · Cited by 12
Cited by
PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps
Li, P., Li, M., Lindberg, M. R., Kennett, M. J., Xiong, N., & Wang, Y. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100239 · Cited by 1,495
Histone Modifications and Cancer
Audia, J. E., & Campbell, R. M. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019521 · Cited by 1,024
Metabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2022) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 770
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
Citrullination regulates pluripotency and histone H1 binding to chromatin
Christophorou, M. A., Castelo-Branco, G., Halley-Stott, R. P., Oliveira, C. S., Loos, R., Radzisheuskaya, A., Mowen, K. A., Bertone, P., Silva, J. C. R., Zernicka-Goetz, M., et al. (2014) · Nature · doi:10.1038/nature12942 · Cited by 412
Metadata
- Authors
- Chang, X., Han, J., Pang, L., Zhao, Y., Yang, Y., & Shen, Z.
- Venue
- BMC Cancer
- Published
- 2009-01-30
- Volume
- 9
- Issue
- 1
- Pages
- 40-40
- ISSN
- 1471-2407 (ISSN-L)
- OpenAlex
- W2010008754
- Cited by
- 255
- References
- 20
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.